tetramethylpyrazine has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, P; Chen, Z; Ge, J; Georgakilas, AG; Hu, H; Pan, X; Tian, S; Xia, L; Yang, Y; Yu, K; Zhang, J; Zhuang, J | 1 |
| Ambati, B; Chen, Z; Ge, J; Pan, X; Tian, S; Yang, Y; Yu, K; Zhang, J; Zhuang, J | 1 |
| Cheng, FC; Cheng, H; Chou, SC; Fu, YS; Fu, YY; Hsu, SY; Kao, LS; Lin, YY; Shih, YH; Tsai, TH; Wang, JY | 1 |
3 other study(ies) available for tetramethylpyrazine and Glioma
| Article | Year |
|---|---|
Tetramethylpyrazine (TMP) protects cerebral neurocytes and inhibits glioma by down regulating chemokine receptor CXCR4 expression.
Topics: Animals; Apoptosis; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Down-Regulation; Glioma; Hydrogen Peroxide; Neurons; Pyrazines; Rats; Receptors, CXCR4 | 2013 |
Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression; Glioma; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Remission Induction; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coculture Techniques; Glioma; Glutamic Acid; Microdialysis; Nerve Degeneration; Neurons; Pyrazines; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2008 |